Exhaled nitric oxide: Standardizing assessment of inflammation in asthma
KEY POINT
A recent review proposes standardization of the assessment of asthma and measuring the fraction of exhaled nitric oxide (eNO) to diagnose asthma, evaluate its control, and determine medication efficacy in treated patients.
SOURCES
Bukstein D et al. Asthma end points and outcomes: what have learned? J Allergy Clin Immunol. 2006;118:S1–15.
